STRATA Skin Sciences Net Income
| SSKN Stock | USD 0.35 0.04 10.26% |
As of the 14th of February 2026, STRATA Skin has the risk adjusted performance of (0.13), and Variance of 90.26. Compared to fundamental indicators, the technical analysis model makes it possible for you to check available technical drivers of STRATA Skin Sciences, as well as the relationship between them.
STRATA Skin Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.3708 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -11.6 M | -12.2 M | |
| Net Loss | -11.6 M | -12.2 M | |
| Net Loss | -3.1 M | -3.3 M | |
| Net Loss | (0.24) | (0.25) | |
| Net Income Per E B T | 0.89 | 0.64 |
STRATA | Net Income | Build AI portfolio with STRATA Stock |
Evaluating STRATA Skin's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into STRATA Skin Sciences's fundamental strength.
Latest STRATA Skin's Net Income Growth Pattern
Below is the plot of the Net Income of STRATA Skin Sciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in STRATA Skin Sciences financial statement analysis. It represents the amount of money remaining after all of STRATA Skin Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is STRATA Skin's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in STRATA Skin's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (10.09 M) | 10 Years Trend |
|
Net Income |
| Timeline |
STRATA Net Income Regression Statistics
| Arithmetic Mean | (11,770,023) | |
| Coefficient Of Variation | (74.90) | |
| Mean Deviation | 7,510,656 | |
| Median | (9,531,270) | |
| Standard Deviation | 8,815,510 | |
| Sample Variance | 77.7T | |
| Range | 25.6M | |
| R-Value | 0.43 | |
| Mean Square Error | 67.7T | |
| R-Squared | 0.18 | |
| Significance | 0.09 | |
| Slope | 748,441 | |
| Total Sum of Squares | 1243.4T |
STRATA Net Income History
Other Fundumenentals of STRATA Skin Sciences
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
STRATA Skin Net Income component correlations
STRATA Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for STRATA Skin is extremely important. It helps to project a fair market value of STRATA Stock properly, considering its historical fundamentals such as Net Income. Since STRATA Skin's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of STRATA Skin's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of STRATA Skin's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could STRATA diversify its offerings? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every STRATA Skin data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.63) | Revenue Per Share | Quarterly Revenue Growth (0.21) | Return On Assets | Return On Equity |
Investors evaluate STRATA Skin Sciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating STRATA Skin's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause STRATA Skin's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, STRATA Skin's market price signifies the transaction level at which participants voluntarily complete trades.
STRATA Skin 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to STRATA Skin's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of STRATA Skin.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in STRATA Skin on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding STRATA Skin Sciences or generate 0.0% return on investment in STRATA Skin over 90 days. STRATA Skin is related to or competes with Heart Test, PAVmed, Biomerica, Neurosense Therapeutics, Meihua International, Inspira Technologies, and Brainstorm Cell. STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatme... More
STRATA Skin Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure STRATA Skin's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess STRATA Skin Sciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 78.88 | |||
| Value At Risk | (9.52) | |||
| Potential Upside | 7.56 |
STRATA Skin Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for STRATA Skin's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as STRATA Skin's standard deviation. In reality, there are many statistical measures that can use STRATA Skin historical prices to predict the future STRATA Skin's volatility.| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (1.84) | |||
| Total Risk Alpha | (2.31) | |||
| Treynor Ratio | (0.41) |
STRATA Skin February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.13) | |||
| Market Risk Adjusted Performance | (0.40) | |||
| Mean Deviation | 4.64 | |||
| Coefficient Of Variation | (596.37) | |||
| Standard Deviation | 9.5 | |||
| Variance | 90.26 | |||
| Information Ratio | (0.18) | |||
| Jensen Alpha | (1.84) | |||
| Total Risk Alpha | (2.31) | |||
| Treynor Ratio | (0.41) | |||
| Maximum Drawdown | 78.88 | |||
| Value At Risk | (9.52) | |||
| Potential Upside | 7.56 | |||
| Skewness | (5.17) | |||
| Kurtosis | 36.17 |
STRATA Skin Sciences Backtested Returns
STRATA Skin Sciences owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.16, which indicates the firm had a -0.16 % return per unit of standard deviation over the last 3 months. STRATA Skin Sciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate STRATA Skin's variance of 90.26, and Risk Adjusted Performance of (0.13) to confirm the risk estimate we provide. The entity has a beta of 3.89, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, STRATA Skin will likely underperform. At this point, STRATA Skin Sciences has a negative expected return of -1.51%. Please make sure to validate STRATA Skin's treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if STRATA Skin Sciences performance from the past will be repeated at some future point.
Auto-correlation | 0.39 |
Below average predictability
STRATA Skin Sciences has below average predictability. Overlapping area represents the amount of predictability between STRATA Skin time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of STRATA Skin Sciences price movement. The serial correlation of 0.39 indicates that just about 39.0% of current STRATA Skin price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.39 | |
| Spearman Rank Test | 0.56 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
STRATA Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, STRATA Skin Sciences reported net income of (10.09 Million). This is 102.96% lower than that of the Health Care Equipment & Supplies sector and 104.24% lower than that of the Health Care industry. The net income for all United States stocks is 101.77% higher than that of the company.
STRATA Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses STRATA Skin's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of STRATA Skin could also be used in its relative valuation, which is a method of valuing STRATA Skin by comparing valuation metrics of similar companies.STRATA Skin is currently under evaluation in net income category among its peers.
STRATA Skin Institutional Holders
Institutional Holdings refers to the ownership stake in STRATA Skin that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of STRATA Skin's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing STRATA Skin's value.| Shares | Bank Of America Corp | 2025-06-30 | 197 | Financial Perspectives Inc | 2025-06-30 | 101 | Hanson Mcclain Inc | 2025-06-30 | 5.0 | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 1.0 | Citadel Advisors Llc | 2025-06-30 | 0.0 | Jpmorgan Chase & Co | 2025-06-30 | 0.0 | 22nw, Lp | 2025-06-30 | 537 K | Nantahala Capital Management, Llc | 2025-06-30 | 403.9 K | Renaissance Technologies Corp | 2025-06-30 | 98 K | Vanguard Group Inc | 2025-06-30 | 84.6 K | Geode Capital Management, Llc | 2025-06-30 | 18.2 K |
STRATA Fundamentals
| Return On Equity | -2.04 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.35) % | ||||
| Operating Margin | (0.27) % | ||||
| Current Valuation | 11.49 M | ||||
| Shares Outstanding | 5.68 M | ||||
| Shares Owned By Insiders | 6.39 % | ||||
| Shares Owned By Institutions | 43.56 % | ||||
| Number Of Shares Shorted | 358.99 K | ||||
| Price To Earning | (0.49) X | ||||
| Price To Book | 1.71 X | ||||
| Price To Sales | 0.07 X | ||||
| Revenue | 33.56 M | ||||
| Gross Profit | 17.89 M | ||||
| EBITDA | (2.84 M) | ||||
| Net Income | (10.09 M) | ||||
| Cash And Equivalents | 10.04 M | ||||
| Cash Per Share | 0.29 X | ||||
| Total Debt | 16.44 M | ||||
| Debt To Equity | 0.35 % | ||||
| Current Ratio | 1.30 X | ||||
| Book Value Per Share | 0.25 X | ||||
| Cash Flow From Operations | 188 K | ||||
| Short Ratio | 5.32 X | ||||
| Earnings Per Share | (2.63) X | ||||
| Price To Earnings To Growth | (0.02) X | ||||
| Target Price | 7.4 | ||||
| Number Of Employees | 106 | ||||
| Beta | 0.32 | ||||
| Market Capitalization | 2.22 M | ||||
| Total Asset | 36.16 M | ||||
| Retained Earnings | (248.14 M) | ||||
| Working Capital | 1.97 M | ||||
| Current Asset | 9.39 M | ||||
| Current Liabilities | 4.62 M | ||||
| Net Asset | 36.16 M |
About STRATA Skin Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze STRATA Skin Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of STRATA Skin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of STRATA Skin Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with STRATA Skin
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if STRATA Skin position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STRATA Skin will appreciate offsetting losses from the drop in the long position's value.Moving together with STRATA Stock
Moving against STRATA Stock
| 0.64 | EDAP | EDAP TMS SA | PairCorr |
| 0.54 | HYB | HOYA | PairCorr |
| 0.53 | EKSO | Ekso Bionics Holdings | PairCorr |
| 0.41 | DXCM | DexCom Inc | PairCorr |
| 0.4 | VREX | Varex Imaging Corp | PairCorr |
The ability to find closely correlated positions to STRATA Skin could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace STRATA Skin when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back STRATA Skin - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling STRATA Skin Sciences to buy it.
The correlation of STRATA Skin is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as STRATA Skin moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if STRATA Skin Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for STRATA Skin can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Will Health Care Equipment & Supplies sector continue expanding? Could STRATA diversify its offerings? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every STRATA Skin data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.63) | Revenue Per Share | Quarterly Revenue Growth (0.21) | Return On Assets | Return On Equity |
Investors evaluate STRATA Skin Sciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating STRATA Skin's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause STRATA Skin's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, STRATA Skin's market price signifies the transaction level at which participants voluntarily complete trades.